Molecular profiling: moving away from tumor philately
JS Reis-Filho, B Weigelt, D Fumagalli… - Science translational …, 2010 - science.org
Despite the remarkable enhancements in breast cancer classification and characterization,
an exhaustive comprehension of the underlying carcinogenic processes and an accurate …
an exhaustive comprehension of the underlying carcinogenic processes and an accurate …
Advances in the proteomic discovery of novel therapeutic targets in cancer
S Guo, J Zou, G Wang - Drug design, development and therapy, 2013 - Taylor & Francis
Proteomic approaches are continuing to make headways in cancer research by helping to
elucidate complex signaling networks that underlie tumorigenesis and disease progression …
elucidate complex signaling networks that underlie tumorigenesis and disease progression …
Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry
Kinases play a prominent role in tumor development, pointing to the presence of specific
phosphorylation patterns in tumor tissues. Here, we investigate whether recently developed …
phosphorylation patterns in tumor tissues. Here, we investigate whether recently developed …
[HTML][HTML] Differential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner
Mutations of genes in tumor cells of Triple Negative subset of Breast Cancer (TNBC)
deregulate pathways of signal transduction. The loss of tumor suppressor gene PTEN is the …
deregulate pathways of signal transduction. The loss of tumor suppressor gene PTEN is the …
Quantified tumor T1 is a generic early-response imaging biomarker for chemotherapy reflecting cell viability
PMJ McSheehy, C Weidensteiner, C Cannet… - Clinical Cancer …, 2010 - AACR
Purpose: Identification of a generic response biomarker by comparison of
chemotherapeutics with different action mechanisms on several noninvasive biomarkers in …
chemotherapeutics with different action mechanisms on several noninvasive biomarkers in …
[HTML][HTML] Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model
Comparative microarray analyses provided insight into understanding transcript changes
during cancer progression; however, a reproducible signature underlying breast …
during cancer progression; however, a reproducible signature underlying breast …
Tumor marker phenotype concordance in second primary breast cancer, California, 1999–2004
M Brown, K Bauer, M Pare - Breast cancer research and treatment, 2010 - Springer
Breast cancer is the most common cancer among women. It is estimated that 7% of women
who have breast cancer will develop a subsequent second independent breast tumor within …
who have breast cancer will develop a subsequent second independent breast tumor within …
Biotechnology and bioinformatics: Advances and applications for bioenergy, bioremediation and biopharmaceutical research
D Thangadurai, J Sangeetha - 2014 - books.google.com
Reflecting the interdisciplinary nature of biotechnology, this book covers the role of targeted
delivery of polymeric nanodrugs to cancer cells, microbial detoxifying enzymes in …
delivery of polymeric nanodrugs to cancer cells, microbial detoxifying enzymes in …
[HTML][HTML] Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and …
JA Sparano, GN Hortobagyi, JR Gralow… - Breast cancer research …, 2010 - Springer
Over 9,000 women with breast cancer are enrolled annually on clinical trials sponsored by
the National Cancer Institute (NCI), accounting for about one-third of all patients enrolled on …
the National Cancer Institute (NCI), accounting for about one-third of all patients enrolled on …
Insights into apoptotic proteins in chemotherapy: quantification techniques and informing therapy choice
J Naß, T Efferth - Expert Review of Proteomics, 2018 - Taylor & Francis
Introduction: Cancer is one of the leading causes of morbidity and mortality worldwide. A
hallmark of cancer is evasion of apoptosis leading to tumor progression and drug resistance …
hallmark of cancer is evasion of apoptosis leading to tumor progression and drug resistance …